Breast Cancer Clinical Trials

Showing 4081-4100 of 5,174 trials

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00003761

This protocol is designed to evaluate the side effects of rV-DF3/MUC1 and to determine the safest dose which should be used in the treatment of breast cancer.

Breast Cancer

Dana-Farber Cancer Institute20 participantsStarted Mar 1999

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +1 more locations

No Longer Available

A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

NCT01120561

This is a multicenter, open-label, single-arm, expanded access study designed to provide T-DM1 to patients with HER2-positive locally advanced or metastatic breast cancer and to evaluate the safety and efficacy of T-DM1 administered by intravenous (IV) infusion.

Metastatic Breast Cancer

Genentech, Inc.Started May 2010

Highland, California, United States • Stockton, California, United States • Denver, Colorado, United States +12 more locations

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

Related Searches

Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer Support

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer

Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver

A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery

Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing Factors

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer